TITLE

No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation

AUTHOR(S)
Bertz, Hartmut; Drognitz, Kathrin; L├╝bbert, Michael
PUB. DATE
January 2014
SOURCE
Annals of Hematology;Jan2014, Vol. 93 Issue 1, p165
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented related to posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics with no differences between them, except costs in patients facing AML chemotherapy.
ACCESSION #
93391766

 

Related Articles

  • Fluconazole/rifabutin interaction.  // Reactions Weekly;9/1/2012, Issue 1417, p23 

    The article describes the case of a 34-year-old man with acquired immune deficiency syndrome (AIDS) who developed thrombocytopenia while receiving treament with rifabutin and high-dose fluconazole.

  • Fluconazole/itraconazole.  // Reactions Weekly;8/11/2012, Issue 1414, p27 

    The article describes the case of a 39-year-old woman who experienced generalised urticaria and pruritus while receiving treatment with itraconazole and fluconazole.

  • Fluconazole.  // Reactions Weekly;Sep2015, Vol. 1569 Issue 1, p110 

    The article presents a case study of a 82-year-old man who had been hospitalised for acute pancreatitis after being tested positive for Candida parapsilosis and developed fluconazole resistant candidaemia and central nervous system infection following treatment with fluconazole.

  • Fluconazole/itraconazole/voriconazole.  // Reactions Weekly;5/4/2013, Issue 1451, p22 

    The article describes the case of a 36-year-old woman who developed breakthrough pulmonary Aspergillus fumigatus infection following long-term azole therapy with fluconazole, itraconazole, and voriconazole.

  • A topical imiquimod-induced oral mucosal lichenoid reaction. Brown, Ronald S.; Farquharson, Andre A. // Journal of the American Dental Association (JADA);Nov2014, Vol. 145 Issue 11, p1141 

    Background. Imiquimod (IMI) is a topical immune response modifier used in the treatment of actinic keratosis and cheilitis. Actinic cheilitis is a potentially premalignant condition that requires therapeutic intervention. IMI therapy is noted for producing cutaneous and mucosal adverse effects....

  • Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. Li Zhang; Meng Xiao; Watts, Matthew R.; He Wang; Xin Fan; Fanrong Kong; Ying-Chun Xu // BMC Infectious Diseases;Aug2015, Vol. 15 Issue 1, p1 

    Background: Candida parapsilosis was the most common species causing candidemia in the 2010 China Hospital Invasive Fungal Surveillance Net (CHIF-NET) database. Compared to Candida albicans, the description of azole resistance and mechanisms in C. parapsilosis is very limited. We report a...

  • Oral fluconazole increases risk of spontaneous abortion.  // Reactions Weekly;1/16/2016, Vol. 1584 Issue 1, p11 

    An abstract of the article "Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth" by D. Molgaard-Nielsen published in the January 2016 issue of the " Journal of the American Medical Association" is presented.

  • Effects of fluconazole on the metabolomic profile of Candida albicans. Katragkou, Aspasia; Alexander, Elizabeth L.; Eoh, Hyungjin; Raheem, Saki K.; Roilides, Emmanuel; Walsh, Thomas J. // Journal of Antimicrobial Chemotherapy (JAC);Mar2016, Vol. 71 Issue 3, p635 

    Background: Little is known about the effects of fluconazole on the metabolism of Candida albicans. We performed LC/MS-based metabolomic profiling of the response of C. albicans cells to increasing doses of fluconazole.Methods: C. albicans cells were cultured to...

  • US FDA advises cautious use of fluconazole during pregnancy.  // Reactions Weekly;5/7/2016, Vol. 1600 Issue 1, p8 

    An abstract of the article "US Food and Drug Administration. Fluconazole (Diflucan): Drug Safety Communication - FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy" is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics